Discussant: DARE-AF AHA Conference Repository

American Heart Association

Final ID:

Discussant: DARE-AF

Yancy, Clyde ( NORTHWESTERN UNIVERSITY , Chicago , Illinois , United States )

Author Disclosures:

Clyde Yancy:

DO NOT have relevant financial relationships

Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Cardiometabolic and Lifestyle Interventions for AF  

Sunday, 11/09/2025 , 08:00AM - 09:15AM

Late-Breaking Science

More abstracts on this topic:

The Does Eliminating Coffee Avoid Fibrillation (DECAF) Trial

Wong Christopher, Moss Joshua, Gerstenfeld Edward, Tseng Zian, Hsia Henry, Lee Randall, Olgin Jeffrey, Vedantham Vasanth, Scheinman Melvin, Lee Catherine, Sanders Prashanthan, Cheung Christopher, Marcus Gregory, Montenegro Gabrielle, Oo Hannah, Pena Isabella, Tang Janet, Tu Samuel, Wall Grace, Dewland Thomas

Dapagliflozin to Reduce Atrial Fibrillation Burden After Catheter Ablation for Atrial Fibrillation in Patients Without Diabetes or Heart Failure: The DARE-AF Randomized Clinical Trial

Zhao Zixu, Dong Jz, Ma Changsheng, Yang Zejun, Jiang Chao, Wang Yiping, Xu Hui, Xu Yang, Sang Caihua, Long Deyong, Du Xin

More abstracts from these authors:

Panel: How do we amplify pediatric cardiology as a field in medicine and retain diverse talent in the field?

Franklin Wayne, Yancy Clyde

Pros and Cons of Prevent

Yancy Clyde